LONDON, UK: The Board of Dechra Pharmaceuticals has announced the acquisition of Ampharmco LLC (APC) and its associated holding companies, Dragon Fire Holdings LLC and Black Griffin Holdings LLC together with its manufacturing site based in Fort Worth, Texas, for a cash consideration of USD 30.0 million (£24.5 million). APC was originally founded in 1999…
Search Results for: FDA Approval
Companion Spine LLC completes global acquisition of Paradigm Spine from Xtant Medical
WURMLINGEN – Companion Spine LLC, the French-American spine implant surgery specialist, announced on Tuesday the completion of its acquisition of the Paradigm Spine business globally from Xtant Medical Holdings, Inc. (NYSE: XTNT). The deal includes the flagship Coflex® Interlaminar Stabilization® device and CoFix® fusion system, along with all related subsidiaries and global business activities. The combined…
Partners Group Private Equity to sell Clario to Thermo Fisher Scientific
LONDON: Partners Group Private Equity Limited (PGPE Ltd) announced Monday the sale of Clario, a leading provider of clinical trial data solutions, to Thermo Fisher Scientific. The transaction, subject to customary regulatory approvals, is expected to close by the end of the second quarter of 2026. Clario, headquartered in Philadelphia, is PGPE Ltd’s eighth-largest portfolio…
AI Technology Group to acquire AVM Biotechnology
SEATTLE: AI Technology Group Inc. (OTCID: AIPG) said Friday it has filed an amended Form 10 with the U.S. Securities and Exchange Commission and signed a definitive agreement to acquire AVM Biotechnology Inc., a clinical-stage biopharmaceutical company developing a novel cancer therapy. Under the agreement dated July 31, 2025, a newly formed subsidiary of AI…
Migrant workers in Canada face lengthy paperwork delays, risking legal status and basic rights
Migrant workers in Canada are experiencing severe delays in processing their work permits and residency applications, leaving many without legal status, access to health care, or the right to work—forcing some into exploitative situations, according to interviews and government data obtained by Reuters. The growing backlog in immigration applications, coupled with shifting policies, has left…
Cosette Pharmaceuticals acquires Mayne Pharma Group for $430 million
NEW YORK: Cosette Pharmaceuticals, Inc., a U.S.-based pharmaceutical company, announced Thursday that it has entered into a definitive agreement to acquire all outstanding shares of Mayne Pharma Group Limited (ASX: MYX) for AUD $7.40 per share. The total consideration for the transaction is approximately USD $430 million. The Boards of Directors of both companies have…
Cotiviti to acquire Edifecs, enhancing healthcare data interoperability
SALT LAKE CITY: Cotiviti, a leader in data-driven healthcare solutions, announced today that it has entered into an agreement to acquire Edifecs, a pioneer in healthcare data interoperability. The combined platform aims to enhance connectivity between payers and providers, increase collaboration in the delivery of care, and accelerate the deployment of value-added solutions within the…
Onego Bio secures EUR 14 million in new funding from European Innovation Council
LONDON: Onego Bio Ltd, an Agronomics company, has secured EUR 14 million in new funding from the European Innovation Council Accelerator Program and an additional Series A investor. In April, Onego announced it closed EUR 37 million in its series A round which, including this new capital, brings Onego’s total funding to date to EUR…
AOTI Inc. commences trading on London Stock Exchange
AOTI has all of the building blocks in place to secure expanded market access and commercialisation of our TWO2 Therapy and to continue the staged roll-out of the NEXA NPWT System
genedrive plc announces multi-tiered shares sale
MANCHESTER, UK: genedrive plc (LSE: GDR), a leader in point-of-care pharmacogenetic testing, has unveiled a comprehensive fundraising initiative aimed at securing approximately £8.1 million. The strategy includes a placing of shares at 1.5 pence each, significantly below the closing price on 8 May 2024, with no underwriting involved. The fundraising is structured into three main…
Poolbeg Pharma signs option agreement to acquire orphan drug candidate
LONDON, UK: Poolbeg Pharma (AIM: POLB) has entered into an exclusive 12-month option agreement with Silk Road Therapeutics Inc, for a nominal fee, to acquire a novel topical muco-adherent formulation of Pentoxifylline (tPTX) for the treatment of oral ulcers in patient’s suffering from Behçet’s Disease. There is a clear unmet medical need for an effective…
Agronomics’ Onego Bio raises €27 million in Series A financing led by NordicNinja VC
LONDON: Agronomics (LSE: ANIC) portfolio company Onego Bio Ltd has successfully raised €27 million in its Series A financing, led by NordicNinja VC, a Japanese-Nordic VC backing companies in climate and deep tech. In addition, Onego Bio secured a further €9.5 million in non-dilutive funding from Business Finland, a government organisation offering grant funding for…